Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview

Area of Science:

• Neuroscience
• Genetics
• Stem Cell Biology

Background:

• Schizophrenia (SCZ) is a complex, polygenic neuropsychiatric disorder impacting quality of life and life expectancy.
• Genetic studies have identified over 100 genomic loci associated with SCZ pathophysiology.
• Transcriptomic studies reveal differentially expressed genes and non-coding RNAs in SCZ patients.

Purpose of the Study:

• To provide a simplified overview of current progress in SCZ genetics and iPSC-based models.
• To synthesize existing literature on SCZ genetics and patient-derived iPSC models.

Main Methods:

• Review and synthesis of literature on schizophrenia genetics.
• Analysis of induced pluripotent stem cell (iPSC)-based models, including 2D neuronal cultures and 3D brain organoids.
• Integration of findings from common and rare variant studies, and transcriptomic analyses.

Main Results:

• Despite extensive genetic and transcriptomic data, causative genes for SCZ remain elusive, complicating animal modeling.
• Induced pluripotent stem cell (iPSC)-based models offer insights into neural phenotypes of SCZ.
• Recent technological advancements have begun to delineate key cellular mechanisms and biological pathways implicated in SCZ.

Conclusions:

• Induced pluripotent stem cell (iPSC) technology is crucial for understanding SCZ neural phenotypes.
• Further research integrating SCZ genetics and iPSC models is necessary for deeper pathophysiological understanding.
• Current approaches are advancing the delineation of cellular mechanisms and biological pathways affected in schizophrenia.